NasdaqGS - Nasdaq Real Time Price USD
Cytek Biosciences, Inc. (CTKB)
2.7100
+0.0400
+(1.50%)
As of 3:54:09 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 2 |
| Avg. Estimate | -0.02 | 0.01 | -0.05 | 0.1 |
| Low Estimate | -0.02 | 0.01 | -0.05 | 0.01 |
| High Estimate | -0.02 | 0.01 | -0.05 | 0.19 |
| Year Ago EPS | -0.01 | 0.06 | 0.18 | -0.05 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 6 | 6 |
| Avg. Estimate | 46.03M | 52.18M | 199.52M | 214.14M |
| Low Estimate | 44.25M | 51.8M | 196M | 200.7M |
| High Estimate | 47.5M | 52.47M | 207.33M | 229.46M |
| Year Ago Sales | 46.62M | 51.5M | 200.45M | 199.52M |
| Sales Growth (year/est) | -1.25% | 1.31% | -0.47% | 7.33% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 0.01 | 0.04 | 0.1 | 0.01 |
| EPS Actual | -0.01 | 0.06 | 0.12 | -0.03 |
| Difference | -0.02 | 0.02 | 0.01 | -0.04 |
| Surprise % | -157.01% | 52.17% | 11.74% | -372.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.02 | 0.01 | -0.05 | 0.1 |
| 7 Days Ago | 0.01 | 0.03 | 0.11 | 0.19 |
| 30 Days Ago | 0.01 | 0.03 | 0.11 | 0.19 |
| 60 Days Ago | 0.01 | 0.03 | 0.11 | 0.19 |
| 90 Days Ago | 0.02 | 0.04 | 0.15 | 0.22 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 1 | 1 | 1 | 1 |
| Down Last 30 Days | 1 | 1 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CTKB | -163.16% | -82.08% | -127.37% | 300.00% |
| S&P 500 | 13.32% | 2.67% | 7.78% | 13.75% |
Upgrades & Downgrades
| Maintains | Goldman Sachs: Sell to Sell | 5/12/2025 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 3/19/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 3/4/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 11/11/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 8/13/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 5/13/2024 |
Related Tickers
QTRX Quanterix Corporation
4.8700
+1.67%
TMCI Treace Medical Concepts, Inc.
6.76
+0.52%
LAB Standard BioTools Inc.
1.0550
-2.31%
AVNS Avanos Medical, Inc.
13.02
-0.68%
SGHT Sight Sciences, Inc.
3.2450
-8.59%
LUNG Pulmonx Corporation
3.3400
-2.62%
RPID Rapid Micro Biosystems, Inc.
3.2850
+2.34%
CVRX CVRx, Inc.
6.87
+8.36%
BBNX Beta Bionics, Inc.
15.23
+6.06%
NPCE NeuroPace, Inc.
17.11
-2.17%